Related Experiment Video

Updated: Jun 5, 2026

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

PKC plays a crucial roles in c-mpl gene expression in megakaryoblastic cells

Masataka Sunohara1, Shigeru Morikawa, Hidetaka Murata

  • 1Department of Anatomy, School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20 Fujimi, Chiyoda-ku, Tokyo 102-8159, Japan.

Okajimas Folia Anatomica Japonica
|December 24, 2010
PubMed

Insights

Protein Kinase C (PKC) activation significantly boosts c-mpl promoter activity in megakaryoblastic cells. Inhibiting PKC with H-7 suppressed this PMA-induced up-regulation, highlighting PKC's key role in c-mpl gene expression.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Signaling

Background:

  • Thrombopoietin (TPO) is a key cytokine regulating megakaryopoiesis.
  • The thrombopoietin receptor, c-Mpl, is crucial for megakaryocyte development.
  • Understanding c-mpl gene regulation is vital for megakaryoblastic cell research.

Purpose of the Study:

  • To investigate the role of Protein Kinase C (PKC) in regulating c-mpl gene expression.
  • To elucidate the mechanisms of c-mpl promoter activity modulation in megakaryoblastic cells.
  • To determine the time-dependent effects of PKC activation and inhibition on c-mpl promoter activity.

Main Methods:

  • Utilized megakaryoblastic cells for experimental analysis.
  • Investigated c-mpl promoter activity using reporter assays.
  • Applied Phorbol 12-myristate 13-acetate (PMA) as a PKC activator.
  • Employed 2-methylpiperazine dihydrochloride (H-7) as a PKC inhibitor.

Main Results:

  • PMA significantly enhanced c-mpl promoter activity in a time-dependent manner.
  • H-7 suppressed the PMA-induced up-regulation of c-mpl promoter activity.
  • The inhibitory effect of H-7 diminished over time, indicating a transient role.

Conclusions:

  • PKC activation is essential for the up-regulation of c-mpl promoter activity in megakaryoblastic cells.
  • PKC plays a critical role in the initiation of PMA-induced c-mpl gene expression.
  • These findings provide insights into the molecular mechanisms governing megakaryopoiesis.

More Related Videos

Isolation of Mouse Megakaryocyte Progenitors10:30

Isolation of Mouse Megakaryocyte Progenitors

Published on: May 20, 2021

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...